首页 > 最新文献

中国综合临床最新文献

英文 中文
Effects of exercise therapy on type 2 diabetes patients in the working mode of " combination of physical and health" “体健结合”工作模式下运动疗法对2型糖尿病患者的影响
Pub Date : 2019-09-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2019.05.006
Jie Zhu, M. Hu, Min Qian, Yifeng Wang, Miaomiao Zhao, Ying-jiu Zhai, K. Mu
Objective To evaluate the effect of aerobic exercise combined with resistance exercise on blood sugar and constitution in patients with type 2 diabetes mellitus. Methods Fifty eligible subjects in community type 2 diabetes database were randomly selected and a model intervention group of " 1+ 2+ 1" was established.The regular exercise intervention was conducted for six months by combining aerobic exercise with resistance exercise.The fasting blood sugar, blood pressure, heart rate, body mass and fat mass before and after intervention were compared by paired t test.Changes in related physical indicators. Results After 6 month of exercise therapy, fasting blood glucose of subjects reduced from (8.58±4.40) mmol/L to (6.29±1.72) mmol/L(P=0.032). Body weight also reduced from (62.44±7.35) Kg to (60.70±7.54) Kg(P=0.008). In physical quality related indexes, fat mass decreased significantly, while protein content increased significantly.There were no changes in muscle mass and fat free body weight.In addition, grip strength and flexion range of subjects significantly increased after exercise therapy.Comprehensive score of physical quality of subjects increased from (73.25±5.65) to (75.48±5.04)(P=0.010). Conclusion Exercise therapy of aerobic exercise combined with resistant exercise can effectively reduce blood glucose, body weight and fat mass, increase muscle strength, flexibility and physical quality.This also reflects that the community-led " health and physical integration" mode of work is an effective means to manage chronic diseases and enhance the physical fitness of residents. Key words: Combination of physical and health; Aerobic exercise; Resistant exercise; Type 2 diabetes
目的探讨有氧运动联合抗阻运动对2型糖尿病患者血糖及体质的影响。方法从社区2型糖尿病数据库中随机抽取50名符合条件的受试者,建立“1+ 2+ 1”模式干预组。以有氧运动与抗阻运动相结合的方式进行为期6个月的常规运动干预。采用配对t检验比较干预前后空腹血糖、血压、心率、体质量、脂肪量。相关物理指标的变化。结果运动治疗6个月后,受试者空腹血糖由(8.58±4.40)mmol/L降至(6.29±1.72)mmol/L(P=0.032)。体重也从(62.44±7.35)Kg下降到(60.70±7.54)Kg(P=0.008)。在体质相关指标中,脂肪量显著降低,蛋白质含量显著增加。肌肉量和无脂肪体重没有变化。此外,运动治疗后,受试者握力和屈曲幅度明显增加。受试者身体素质综合评分由(73.25±5.65)分上升至(75.48±5.04)分(P=0.010)。结论有氧运动结合抗阻运动的运动疗法能有效降低血糖、体重和脂肪量,提高肌肉力量、柔韧性和身体素质。这也反映出社区主导的“健体结合”工作模式是管理慢性病、增强居民体质的有效手段。关键词:体质与健康结合;有氧运动;抵抗运动;2型糖尿病
{"title":"Effects of exercise therapy on type 2 diabetes patients in the working mode of \" combination of physical and health\"","authors":"Jie Zhu, M. Hu, Min Qian, Yifeng Wang, Miaomiao Zhao, Ying-jiu Zhai, K. Mu","doi":"10.3760/CMA.J.ISSN.1008-6315.2019.05.006","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2019.05.006","url":null,"abstract":"Objective \u0000To evaluate the effect of aerobic exercise combined with resistance exercise on blood sugar and constitution in patients with type 2 diabetes mellitus. \u0000 \u0000 \u0000Methods \u0000Fifty eligible subjects in community type 2 diabetes database were randomly selected and a model intervention group of \" 1+ 2+ 1\" was established.The regular exercise intervention was conducted for six months by combining aerobic exercise with resistance exercise.The fasting blood sugar, blood pressure, heart rate, body mass and fat mass before and after intervention were compared by paired t test.Changes in related physical indicators. \u0000 \u0000 \u0000Results \u0000After 6 month of exercise therapy, fasting blood glucose of subjects reduced from (8.58±4.40) mmol/L to (6.29±1.72) mmol/L(P=0.032). Body weight also reduced from (62.44±7.35) Kg to (60.70±7.54) Kg(P=0.008). In physical quality related indexes, fat mass decreased significantly, while protein content increased significantly.There were no changes in muscle mass and fat free body weight.In addition, grip strength and flexion range of subjects significantly increased after exercise therapy.Comprehensive score of physical quality of subjects increased from (73.25±5.65) to (75.48±5.04)(P=0.010). \u0000 \u0000 \u0000Conclusion \u0000Exercise therapy of aerobic exercise combined with resistant exercise can effectively reduce blood glucose, body weight and fat mass, increase muscle strength, flexibility and physical quality.This also reflects that the community-led \" health and physical integration\" mode of work is an effective means to manage chronic diseases and enhance the physical fitness of residents. \u0000 \u0000 \u0000Key words: \u0000Combination of physical and health; Aerobic exercise; Resistant exercise; Type 2 diabetes","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47166576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of XELOX regimens plus combination of endostar and thalidamide as first-line treatment for advanced colorectal cancer XELOX方案联合恩妥他和沙利度胺一线治疗晚期癌症的疗效
Pub Date : 2019-09-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2019.05.012
Yuzhi Li, Y. Bao, F. Sun
Objective To investigate the efficacy and safety of two antiangiogenic drugs (recombinant human endostatin endostar and thalidomide) combined with capecitabine and oxaliplatin(XELOX) regimens in the treatment of advanced colorectal cancer. Methods From January 2015 to May 2018, 40 patients of advanced metastatic colorectal cancer with organ metastasis and non-resectable were selected from the first people′s hospital of Hefei and Anhui Provincial Hospital, and they were randomly divided into treatment and control group, with 20 cases in each group.The treatment group received intravenous infusion (IV) of endostar for continuous 7 days (day 1~7) combined with oral administration of thalidomide for continuous 14 days (day 1~14) plus XELOX regimens after the fifth dose of endostar (day 6~19), and the control group was treated with XELOX regimen (day6~19). Results The objective response rate (ORR) was 50% (10/20) and 20% (4/20) respectively (χ2=3.956, P 0.05), and the median progression free survival (mPFS) was 6.8 in both groups.There was no significant difference in Karnofsky performance score (KPS) and incidence of adverse reactions between the two groups before and after treatment (P>0.05). Conclusion Combination of endostar and thalidamide plus XELOX regimen as first-line treatment have better antitumor activity and are well-tolerated in patients with advanced colorectal cancer. Key words: Recombinant human endostatin; Endostar; Thalidomide; Advanced colorectal cancer
目的探讨两种抗血管生成药物(重组人内皮抑素恩度达和沙利度胺)联合卡培他滨和奥沙利铂(XELOX)方案治疗晚期结直肠癌的疗效和安全性。方法选取2015年1月~ 2018年5月合肥市第一人民医院和安徽省省级医院的40例晚期转移性结直肠癌脏器转移不可切除患者,随机分为治疗组和对照组,每组20例。治疗组给予恩度静脉滴注(IV),连续7天(第1~7天),联合口服沙利度胺,连续14天(第1~14天),在恩度第5剂(第6~19天)后加XELOX方案治疗,对照组给予XELOX方案治疗(第6~19天)。结果两组患者客观缓解率(ORR)分别为50%(10/20)和20% (4/20)(χ2=3.956, p0.05),中位无进展生存期(mPFS)为6.8。两组患者治疗前后Karnofsky绩效评分(KPS)及不良反应发生率比较,差异均无统计学意义(P < 0.05)。结论恩度联合沙利达胺联合XELOX方案作为一线治疗对晚期结直肠癌患者具有较好的抗肿瘤活性和良好的耐受性。关键词:重组人内皮抑素;Endostar;萨力多胺;晚期结直肠癌
{"title":"Effect of XELOX regimens plus combination of endostar and thalidamide as first-line treatment for advanced colorectal cancer","authors":"Yuzhi Li, Y. Bao, F. Sun","doi":"10.3760/CMA.J.ISSN.1008-6315.2019.05.012","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2019.05.012","url":null,"abstract":"Objective \u0000To investigate the efficacy and safety of two antiangiogenic drugs (recombinant human endostatin endostar and thalidomide) combined with capecitabine and oxaliplatin(XELOX) regimens in the treatment of advanced colorectal cancer. \u0000 \u0000 \u0000Methods \u0000From January 2015 to May 2018, 40 patients of advanced metastatic colorectal cancer with organ metastasis and non-resectable were selected from the first people′s hospital of Hefei and Anhui Provincial Hospital, and they were randomly divided into treatment and control group, with 20 cases in each group.The treatment group received intravenous infusion (IV) of endostar for continuous 7 days (day 1~7) combined with oral administration of thalidomide for continuous 14 days (day 1~14) plus XELOX regimens after the fifth dose of endostar (day 6~19), and the control group was treated with XELOX regimen (day6~19). \u0000 \u0000 \u0000Results \u0000The objective response rate (ORR) was 50% (10/20) and 20% (4/20) respectively (χ2=3.956, P 0.05), and the median progression free survival (mPFS) was 6.8 in both groups.There was no significant difference in Karnofsky performance score (KPS) and incidence of adverse reactions between the two groups before and after treatment (P>0.05). \u0000 \u0000 \u0000Conclusion \u0000Combination of endostar and thalidamide plus XELOX regimen as first-line treatment have better antitumor activity and are well-tolerated in patients with advanced colorectal cancer. \u0000 \u0000 \u0000Key words: \u0000Recombinant human endostatin; Endostar; Thalidomide; Advanced colorectal cancer","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46137380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plastic bronchitis associated with bleeding in child: A case report and literature review 儿童可塑性支气管炎伴出血1例报告及文献复习
Pub Date : 2019-09-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2019.05.020
Yan-hua Hu
Objective To analyze the clinical diagnosis and treatment of a child with hemorrhagic plastic bronchitis, and to explore the etiology of hemorrhagic plastic bronchitis with review of relevant literature, so as to improve the clinicians′understanding of plastic bronchitis. Methods Clinical data of a female children with hemorrhagic plastic bronchitis was retrospectively reviewed.The patient had congenital heart disease, with repeated cough and hemoptysis as the first symptom.Chest CT scan showed cylindrical bronchiectasis of the right lower lobe and the bloodly bronchial cast was removed by bronchoscopy.The related literatures were review. Results After treatment, the symptoms of cough and cough were improved significantly. Conclusion When patients with recurrent hemoptysis and conventional treatment has no effective, it should be alert to the possibility of plastic bronchitis.The bronchoscopy can identify the causes and remove the casts, also need to pay attention to rebleeding. Key words: Plastic bronchitics; Bleeding; Children
目的分析1例儿童出血性可塑性支气管炎的临床诊断和治疗,并结合相关文献探讨出血性可塑性支气管炎的病因,提高临床医生对可塑性支气管炎的认识。方法回顾性分析1例女童出血性可塑性支气管炎的临床资料。患者有先天性心脏病,以反复咳嗽和咯血为首发症状。胸部CT示右下叶圆柱形支气管扩张,支气管镜下取出带血支气管铸型。对相关文献进行了综述。结果治疗后咳嗽、咳嗽症状明显好转。结论当反复咯血患者经常规治疗均无效时,应警惕可塑性支气管炎的可能性。支气管镜检查可以识别病因并取出铸型,也需要注意再出血。关键词:塑性支气管炎;出血;孩子们
{"title":"Plastic bronchitis associated with bleeding in child: A case report and literature review","authors":"Yan-hua Hu","doi":"10.3760/CMA.J.ISSN.1008-6315.2019.05.020","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2019.05.020","url":null,"abstract":"Objective \u0000To analyze the clinical diagnosis and treatment of a child with hemorrhagic plastic bronchitis, and to explore the etiology of hemorrhagic plastic bronchitis with review of relevant literature, so as to improve the clinicians′understanding of plastic bronchitis. \u0000 \u0000 \u0000Methods \u0000Clinical data of a female children with hemorrhagic plastic bronchitis was retrospectively reviewed.The patient had congenital heart disease, with repeated cough and hemoptysis as the first symptom.Chest CT scan showed cylindrical bronchiectasis of the right lower lobe and the bloodly bronchial cast was removed by bronchoscopy.The related literatures were review. \u0000 \u0000 \u0000Results \u0000After treatment, the symptoms of cough and cough were improved significantly. \u0000 \u0000 \u0000Conclusion \u0000When patients with recurrent hemoptysis and conventional treatment has no effective, it should be alert to the possibility of plastic bronchitis.The bronchoscopy can identify the causes and remove the casts, also need to pay attention to rebleeding. \u0000 \u0000 \u0000Key words: \u0000Plastic bronchitics; Bleeding; Children","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44770091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of myocardial injury caused by allergy 过敏性心肌损伤1例
Pub Date : 2019-09-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2019.05.021
Dongmei Zhang
Objective Urticaria, itchy skin, chest tightness, abdominal pain and anaphylactic shock are the common clinical manifestations of allergic reactions.In addition, the relevant literature indicates that allergies can cause coronary vasospasm or rupture of atherosclerotic plaque, leading to acute coronary syndrome, which is named Kounis syndrome.Here we report a case of a child admitted to the emergency departments with myocardial injury and ST depression on electrocardiography while a severe allergic reaction.The patient was discharged from the hospital after receiving anti-allergic and nutritional myocardial medication.I hope that we can learn more about Kounis syndrome through this case. Key words: Allergic reaction; Myocardial injury; Allergic angina; Kounis syndrome
目的荨麻疹、皮肤瘙痒、胸闷、腹痛和过敏性休克是过敏反应的常见临床表现。此外,相关文献表明,过敏可引起冠状动脉血管痉挛或动脉粥样硬化斑块破裂,导致急性冠状动脉综合征,称为库尼斯综合征。在这里,我们报告了一例儿童因心肌损伤和心电图ST段压低而进入急诊室,同时出现严重过敏反应。患者在接受抗过敏和营养性心肌药物治疗后出院。我希望我们能通过这个病例了解更多关于库尼斯综合征的信息。关键词:过敏反应;心肌损伤;过敏性心绞痛;库尼斯综合征
{"title":"A case of myocardial injury caused by allergy","authors":"Dongmei Zhang","doi":"10.3760/CMA.J.ISSN.1008-6315.2019.05.021","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2019.05.021","url":null,"abstract":"Objective \u0000Urticaria, itchy skin, chest tightness, abdominal pain and anaphylactic shock are the common clinical manifestations of allergic reactions.In addition, the relevant literature indicates that allergies can cause coronary vasospasm or rupture of atherosclerotic plaque, leading to acute coronary syndrome, which is named Kounis syndrome.Here we report a case of a child admitted to the emergency departments with myocardial injury and ST depression on electrocardiography while a severe allergic reaction.The patient was discharged from the hospital after receiving anti-allergic and nutritional myocardial medication.I hope that we can learn more about Kounis syndrome through this case. \u0000 \u0000 \u0000Key words: \u0000Allergic reaction; Myocardial injury; Allergic angina; Kounis syndrome","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46348875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical analysis of 33 cases on laparoscopic resection of presacral cysts 腹腔镜下骶前囊肿切除术33例临床分析
Pub Date : 2019-09-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2019.05.016
B. Niu, Jiaolin Zhou, Bin Wu
Objective To summarize and analyze our experiences uponperforming laparoscopic resection ofpresacral cysts, at the aim of generalizing the minimally invasive surgery in the treatment of this disease. Methods The clinical data of 33 patients with presacral cysts treated by laparoscopy in Peking Union Medical College Hospital of Chinese Academy of Medical Sciences from November 2012 to June 2017 were retrospectively analyzed.The operation time, the incidence of intraoperative and postoperative complications and the length of hospital stay were counted. Results Tumor excision was completed according to the plan without conversion to open surgery.The average operation time was (124.4±63.0) minutes.There were 1 case of rectal injury and 1 case of presacral venous plexus hemorrhage.The complications were 6%.Postoperative rectal leakage occurred in 2 cases (6%). The average hospitalization time after operation was (6.7±4.3) days.Of 33 cases, 2 cases were lost.One case had recurrence of presacral cyst one year after operation. Conclusion Laparoscopic resection of presacral cysts is technically feasible, and helps to improve intraoperative exposure, increase operating space and improve the resection rate of tumors. Key words: Laparoscopy; Presacral space; Retrorectal cyst
目的总结和分析腹腔镜下骶髂囊肿切除术的经验,以期推广微创手术治疗该病。方法回顾性分析2012年11月至2017年6月在中国医学科学院北京协和医院腹腔镜治疗骶前囊肿33例的临床资料。统计手术时间、术中和术后并发症的发生率以及住院时间。结果肿瘤切除按计划完成,未转为开放手术。平均手术时间为(124.4±63.0)分钟。直肠损伤1例,骶前静脉丛出血1例。并发症发生率6%,术后发生直肠瘘2例(6%)。术后平均住院时间为(6.7±4.3)天。33例中,2例失联。1例术后1年骶前囊肿复发。结论腹腔镜骶前囊肿切除术在技术上是可行的,有助于提高术中暴露量,增加手术空间,提高肿瘤切除率。关键词:腹腔镜;肢前间隙;直肠后囊肿
{"title":"Clinical analysis of 33 cases on laparoscopic resection of presacral cysts","authors":"B. Niu, Jiaolin Zhou, Bin Wu","doi":"10.3760/CMA.J.ISSN.1008-6315.2019.05.016","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2019.05.016","url":null,"abstract":"Objective \u0000To summarize and analyze our experiences uponperforming laparoscopic resection ofpresacral cysts, at the aim of generalizing the minimally invasive surgery in the treatment of this disease. \u0000 \u0000 \u0000Methods \u0000The clinical data of 33 patients with presacral cysts treated by laparoscopy in Peking Union Medical College Hospital of Chinese Academy of Medical Sciences from November 2012 to June 2017 were retrospectively analyzed.The operation time, the incidence of intraoperative and postoperative complications and the length of hospital stay were counted. \u0000 \u0000 \u0000Results \u0000Tumor excision was completed according to the plan without conversion to open surgery.The average operation time was (124.4±63.0) minutes.There were 1 case of rectal injury and 1 case of presacral venous plexus hemorrhage.The complications were 6%.Postoperative rectal leakage occurred in 2 cases (6%). The average hospitalization time after operation was (6.7±4.3) days.Of 33 cases, 2 cases were lost.One case had recurrence of presacral cyst one year after operation. \u0000 \u0000 \u0000Conclusion \u0000Laparoscopic resection of presacral cysts is technically feasible, and helps to improve intraoperative exposure, increase operating space and improve the resection rate of tumors. \u0000 \u0000 \u0000Key words: \u0000Laparoscopy; Presacral space; Retrorectal cyst","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41309187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors of mortality in peritoneal dialysis patients 腹膜透析患者死亡的危险因素
Pub Date : 2019-09-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2019.05.014
Lihong Wang
Objective To explore the risk factors affecting the death of peritoneal dialysis patients. Methods The clinical data of 275 patients with peritoneal dialysis who place a peritoneal catheter in the Department of Nephrology, First Affiliated Hospital of Guangxi Medical University and had regular peritoneal dialysis for more than 3 months from January 1, 2005 to December 31, 2015 were retrospectively analyzed.Sixty patients died in the observation group, and 215 patients who continued regular peritoneal dialysis were in the control group.Univariate analysis and two-class logistic regression analysis were used to analyze risk factors for death. Results The composition ratio of the primary disease to diabetic nephropathy in the death group and the control group was 15.0% (9/60) and 5.6% (12/215), respectively, the average age of patients entering peritoneal dialysis was (50.6±14.3) years old and (45.7±13.2) years old, respectively(t=-2.518), glomerular filtration rates were 6.0(4.5, 9.4) and 5.1(4.2, 6.6), respectively, blood potassium is (4.2±0.7) mmol/L and (4.5±0.7) mmol/L, respectively, serum creatinine was 721.0 (585.0, 891.3) μmol/L and 847 (723.3, 1 033.3) μmol/L, respectively, there were significant differences between the two groups (t=2.14, all P<0.05). Logistic regression analysis indicated that the primary disease was diabetic nephropathy, and the age of admission to peritoneal dialysis, glomerular filtration rate, blood uric acid are risk factors for death in peritoneal dialysis patients. Conclusion Diabetic nephropathy, age, glomerular filtration rate, and blood uric acid level are independent risk factors for death in peritoneal dialysis patients. Key words: Peritoneal dialysis; Glomerular filtration rate; Risk factors
目的探讨影响腹膜透析患者死亡的危险因素。方法回顾性分析2005年1月1日至2015年12月31日在广西医科大学第一附属医院肾内科放置腹膜导管并定期腹膜透析3个月以上的275例腹膜透析患者的临床资料。观察组有60名患者死亡,对照组有215名患者继续定期腹膜透析。采用单因素分析和二类逻辑回归分析对死亡危险因素进行分析。结果死亡组和对照组原发性疾病与糖尿病肾病的构成比分别为15.0%(9/60)和5.6%(12/215),进入腹膜透析的患者平均年龄分别为(50.6±14.3)岁和(45.7±13.2)岁(t=-2.518),肾小球滤过率分别为6.0(4.5,9.4)和5.1(4.2,6.6),血钾分别为(4.2±0.7)mmol/L和(4.5±0.7)mol/L,血肌酐分别为721.0(585.0891.3)μmol/L和847(723.31033.3)μmol/L,两组比较有显著性差异(t=2.14,均P<0.05),肾小球滤过率、血尿酸是腹膜透析患者死亡的危险因素。结论糖尿病肾病、年龄、肾小球滤过率、血尿酸水平是腹膜透析患者死亡的独立危险因素。关键词:腹膜透析;肾小球滤过率;风险因素
{"title":"Risk factors of mortality in peritoneal dialysis patients","authors":"Lihong Wang","doi":"10.3760/CMA.J.ISSN.1008-6315.2019.05.014","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2019.05.014","url":null,"abstract":"Objective \u0000To explore the risk factors affecting the death of peritoneal dialysis patients. \u0000 \u0000 \u0000Methods \u0000The clinical data of 275 patients with peritoneal dialysis who place a peritoneal catheter in the Department of Nephrology, First Affiliated Hospital of Guangxi Medical University and had regular peritoneal dialysis for more than 3 months from January 1, 2005 to December 31, 2015 were retrospectively analyzed.Sixty patients died in the observation group, and 215 patients who continued regular peritoneal dialysis were in the control group.Univariate analysis and two-class logistic regression analysis were used to analyze risk factors for death. \u0000 \u0000 \u0000Results \u0000The composition ratio of the primary disease to diabetic nephropathy in the death group and the control group was 15.0% (9/60) and 5.6% (12/215), respectively, the average age of patients entering peritoneal dialysis was (50.6±14.3) years old and (45.7±13.2) years old, respectively(t=-2.518), glomerular filtration rates were 6.0(4.5, 9.4) and 5.1(4.2, 6.6), respectively, blood potassium is (4.2±0.7) mmol/L and (4.5±0.7) mmol/L, respectively, serum creatinine was 721.0 (585.0, 891.3) μmol/L and 847 (723.3, 1 033.3) μmol/L, respectively, there were significant differences between the two groups (t=2.14, all P<0.05). Logistic regression analysis indicated that the primary disease was diabetic nephropathy, and the age of admission to peritoneal dialysis, glomerular filtration rate, blood uric acid are risk factors for death in peritoneal dialysis patients. \u0000 \u0000 \u0000Conclusion \u0000Diabetic nephropathy, age, glomerular filtration rate, and blood uric acid level are independent risk factors for death in peritoneal dialysis patients. \u0000 \u0000 \u0000Key words: \u0000Peritoneal dialysis; Glomerular filtration rate; Risk factors","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46458199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical follow-up study of paclitaxel-coated balloon in the treatment of symptomatic lower extremity arteriosclerosis obliterans 紫杉醇涂层球囊治疗症状性下肢动脉硬化闭塞症的临床随访研究
Pub Date : 2019-09-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2019.05.019
Feifei Li, Wenhua Li, Jingmin Ou
Objective To investigate the clinical effect of paclitaxel coated balloon in the treatment of symptomatic lower extremity arteriosclerosis obliterans. Methods From January 2016 to April 2017, 64 patients with symptomatic lower limb arteriosclerosis obliterans (ASO) of femoral and popliteal artery stenosis admitted to Chongming Branch Xinhua Hospital affiliated to Shanghai Jiaotong University School of Medicine were selected as the research subjects.According to the principle of randomization, they were divided into two groups, 32 cases in each group.In the drug-coated group, ordinary balloon was pre-expanded, and then paclitaxel drug-coated balloon was used to expand.If there were still retraction and stenosis of diseased vessels, which affected the blood flow of lower limbs, remedial stents were implanted.Bare stent group used a slightly smaller balloon to pre-expand superficial femoral artery and then release the stent.After one year follow-up, the changes of ankle-brachial index (ABI), restenosis rate of target lesion vessels, Rutherford grading changes, clinical drive target vessel revascularization rate, perioperative period, death rate of patients during follow-up period, amputation rate and complication rate were observed. Results There were no amputations or deaths in the whole group during the perioperative period and follow-up.The incidence of complications in the drug-coated group was 3.1% (1/32), significantly lower than that in the bare stent group 18.8% (6/32) (χ2=4.010, P=0.045). Before treatment, the ABI of patients in drug-coated group and bare stent group at 6 months and 12 months after treatment were significantly different (Finter-group=7.028, Pinter-group=0.024, Fintra-group=219.028, Pintra-group=0.000, Finteraction=350.028, Pinteraction=0.000), and ABI of the two groups at 12 months after treatment were (0.73±0.11) and (0.68±0.09), respectively, the difference was statistically significant (t=1.990, P=0.025). Six months after operation, the restenosis rates of target lesions in the two groups were 9.4%(3/32) and 15.6%(5/32), respectively, with no significant difference (χ2=0.571, P=0.450); The restenosis rate of bare stent group was 37.5%(12/32) 12 months after operation, which was significantly higher than that of drug-coated group by 15.6%(5/32) (χ2=3.925, P=0.048). Clinical observation results showed that 12 months after operation, the target-lesion revascularization (TLR) of the drug-coated group was 3.1% (1/32) and that of the bare stent group was 9.4% (3/32), with no significant difference.Rutherford grading was improved in both groups(χ2=1.067, P>0.05). Conclusion Paclitaxel drug-coated balloon is safe and effective in the treatment of symptomatic lower limb arteriosclerosis obliterans, which is worthy of clinical application. Key words: Arterial occlusion of the lower limb; Drug-coated balloon; Paclitaxel; Restenosis; Ankle brachial index
目的探讨紫杉醇涂层球囊治疗症状性下肢动脉硬化闭塞症的临床疗效。方法选择2016年1月至2017年4月上海交通大学医学院附属新华医院崇明分院收治的64例股腘动脉狭窄症状性下肢动脉硬化闭塞症患者作为研究对象。根据随机化原则,将患者分为两组,每组32例。药物包被组先用普通球囊预扩张,再用紫杉醇药物包被球囊扩张。如果病变血管仍有回缩和狭窄,影响下肢血流,则植入治疗性支架。裸支架组使用稍小的球囊预扩张股浅动脉,然后释放支架。随访一年,观察踝臂指数(ABI)、靶病变血管再狭窄率、Rutherford分级变化、临床驱动靶血管血运重建率、围手术期、随访期患者死亡率、截肢率和并发症发生率的变化。结果整个组在围手术期和随访期间均无截肢或死亡。药物涂层组并发症发生率为3.1%(1/32),明显低于裸支架组18.8%(6/32)(χ2=4.010,P=0.045),药物包被组和裸支架组患者在治疗后6个月和12个月的ABI有显著差异(Finter组=7.028,Pinter组=0.024,Fintra组=221.028,Pintra组=0.000,Finteract=350.028,Pinteract=0.000),两组在治疗后12个月ABI分别为(0.73±0.11)和(0.68±0.09),术后6个月,两组靶病变再狭窄率分别为9.4%(3/32)和15.6%(5/32),差异无统计学意义(χ2=0.571,P=0.450);裸支架组术后12个月再狭窄率为37.5%(12/32),明显高于药物包被组15.6%(5/32)(χ2=3.925,P=0.048),差异无统计学意义。结论紫杉醇药物包被球囊治疗下肢动脉硬化闭塞症安全有效,值得临床应用。关键词:下肢动脉闭塞;药物包被球囊;紫杉醇;再狭窄;踝臂指数
{"title":"Clinical follow-up study of paclitaxel-coated balloon in the treatment of symptomatic lower extremity arteriosclerosis obliterans","authors":"Feifei Li, Wenhua Li, Jingmin Ou","doi":"10.3760/CMA.J.ISSN.1008-6315.2019.05.019","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2019.05.019","url":null,"abstract":"Objective \u0000To investigate the clinical effect of paclitaxel coated balloon in the treatment of symptomatic lower extremity arteriosclerosis obliterans. \u0000 \u0000 \u0000Methods \u0000From January 2016 to April 2017, 64 patients with symptomatic lower limb arteriosclerosis obliterans (ASO) of femoral and popliteal artery stenosis admitted to Chongming Branch Xinhua Hospital affiliated to Shanghai Jiaotong University School of Medicine were selected as the research subjects.According to the principle of randomization, they were divided into two groups, 32 cases in each group.In the drug-coated group, ordinary balloon was pre-expanded, and then paclitaxel drug-coated balloon was used to expand.If there were still retraction and stenosis of diseased vessels, which affected the blood flow of lower limbs, remedial stents were implanted.Bare stent group used a slightly smaller balloon to pre-expand superficial femoral artery and then release the stent.After one year follow-up, the changes of ankle-brachial index (ABI), restenosis rate of target lesion vessels, Rutherford grading changes, clinical drive target vessel revascularization rate, perioperative period, death rate of patients during follow-up period, amputation rate and complication rate were observed. \u0000 \u0000 \u0000Results \u0000There were no amputations or deaths in the whole group during the perioperative period and follow-up.The incidence of complications in the drug-coated group was 3.1% (1/32), significantly lower than that in the bare stent group 18.8% (6/32) (χ2=4.010, P=0.045). Before treatment, the ABI of patients in drug-coated group and bare stent group at 6 months and 12 months after treatment were significantly different (Finter-group=7.028, Pinter-group=0.024, Fintra-group=219.028, Pintra-group=0.000, Finteraction=350.028, Pinteraction=0.000), and ABI of the two groups at 12 months after treatment were (0.73±0.11) and (0.68±0.09), respectively, the difference was statistically significant (t=1.990, P=0.025). Six months after operation, the restenosis rates of target lesions in the two groups were 9.4%(3/32) and 15.6%(5/32), respectively, with no significant difference (χ2=0.571, P=0.450); The restenosis rate of bare stent group was 37.5%(12/32) 12 months after operation, which was significantly higher than that of drug-coated group by 15.6%(5/32) (χ2=3.925, P=0.048). Clinical observation results showed that 12 months after operation, the target-lesion revascularization (TLR) of the drug-coated group was 3.1% (1/32) and that of the bare stent group was 9.4% (3/32), with no significant difference.Rutherford grading was improved in both groups(χ2=1.067, P>0.05). \u0000 \u0000 \u0000Conclusion \u0000Paclitaxel drug-coated balloon is safe and effective in the treatment of symptomatic lower limb arteriosclerosis obliterans, which is worthy of clinical application. \u0000 \u0000 \u0000Key words: \u0000Arterial occlusion of the lower limb; Drug-coated balloon; Paclitaxel; Restenosis; Ankle brachial index","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48175132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between preoperative programmed death receptor 1, programmed death ligand 1 and clinical pathological parameters, early postoperative recurrence and metastasis in Patients with Esophageal Squamous Cell Carcinoma 食管鳞状细胞癌术前程序性死亡受体1、程序性死亡配体1与临床病理参数及术后早期复发转移的关系
Pub Date : 2019-09-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2019.05.007
Gen-jie Wang, Liang-yun Ma, Yu-zhou Shen
Objective To investigate the relationship between programmed death 1 (PD-1), programmed death receptor-1 ligand (PD-L1) and clinical pathological parameters, early postoperative recurrence and metastasis in patients with esophageal squamous cell carcinoma. Methods The retrospectively analyze of Paraffin tissue specimens and clinical pathology data in 58 Patients undergoing radical esophageal squamous cell carcinoma surgery from January 2015 to January 2017 in the 910 hospital of PLA Joint Service Support force were performed.Expression of PD-1 and PD-L1 in esophageal squamous cell carcinoma and normal esophageal mucosa were detected by SP immunohistochemical staining.The positive expression rates of PD-1 and PD-L1 in normal esophageal mucosa and esophageal squamous cell carcinoma were compared.the relationship between PD-1 and PD-L1 and gender, age, family history, depth of tumor invasion, degree of differentiation, lymph node metastasis, and TNM staging were analyzed.Follow-up was performed by outpatient consultation and telephone consultation.The recurrence and metastasis of early postoperative (≤1 year) was analyzed.The PD-1 and PD-L1 in esophageal squamous cell carcinoma were analyzed in patients with recurrent metastasis and non-relapsing and metastasis. Results The positive expression rate of PD-1 in esophageal squamous cell carcinoma was 37.93%(22/58), which was significantly higher than that in normal esophageal mucosa 15.52%(9/58). The difference was statistically significant (χ2=7.440, P=0.006). The positive expression rate of PD-L1 in esophageal squamous cell carcinoma was 43.10%(25/58), which was significantly higher than that of normal esophageal mucosa 18.97%(11/58). The difference was statistically significant (χ2=7.894, P=0.005). There was a difference in the positive expression rate of PD-L1 between different infiltration depth and TNM stage, P 0.05). The positive expression rate of PD-L1 in the recurrence group was 71.43% (10/14), and that in the non-recurrent group was 34.09% (15/44). The difference was statistically significant, (χ2=6.037, P<0.05). Conclusion The expression of PD-1 and PD-L1 in cancer tissues of patients with esophageal squamous cell carcinoma is highly expressed.PD-L1 is closely related to the occurrence and progression of esophageal squamous cell carcinoma, and it is also an important index affecting early recurrence and metastasis.Which can be selected as a new target for early diagnosis and treatment. Key words: Esophageal squamous cell carcinoma; Programmed death 1; Programmed death receptor-1 ligand; Clinicopathological features; Recurrence and metastasis; Correlation
目的探讨程序性死亡1(PD-1)、程序性死亡受体1配体(PD-L1)与食管鳞状细胞癌临床病理参数、术后早期复发和转移的关系。方法回顾性分析2015年1月至2017年1月在中国人民解放军联勤保障部队910医院接受食管鳞状细胞癌根治术的58例患者的石蜡组织标本和临床病理资料。应用免疫组化SP法检测PD-1和PD-L1在食管鳞状细胞癌和正常食管黏膜中的表达。比较PD-1和PD-L1在正常食管黏膜和食管鳞状细胞癌中的阳性表达率,分析其与性别、年龄、家族史、肿瘤浸润深度、分化程度、淋巴结转移和TNM分期的关系。通过门诊咨询和电话咨询进行随访。分析术后早期(≤1年)的复发和转移情况。分析食管鳞状细胞癌复发转移和非复发转移患者的PD-1和PD-L1。结果PD-1在食管鳞状细胞癌中的阳性表达率为37.93%(22/58),明显高于正常食管粘膜中的15.52%(9/58),差异有统计学意义(χ2=7.440,P=0.006),差异有统计学意义(χ2=7.894,P=0.005),不同浸润深度和TNM分期的PD-L1阳性表达率有差异(P<0.05),复发组PD-L1阳性阳性表达率为71.43%(10/14),非复发组为34.09%(15/44)。结论PD-1和PD-L1在食管鳞状细胞癌癌症组织中表达较高。PD-L1与食管鳞状细胞癌的发生、发展密切相关,也是影响早期复发和转移的重要指标。可作为早期诊断和治疗的新靶点。关键词:食管鳞状细胞癌;程序性死亡1;程序性死亡受体-1配体;临床病理特征;复发和转移;相关性
{"title":"Relationship between preoperative programmed death receptor 1, programmed death ligand 1 and clinical pathological parameters, early postoperative recurrence and metastasis in Patients with Esophageal Squamous Cell Carcinoma","authors":"Gen-jie Wang, Liang-yun Ma, Yu-zhou Shen","doi":"10.3760/CMA.J.ISSN.1008-6315.2019.05.007","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2019.05.007","url":null,"abstract":"Objective \u0000To investigate the relationship between programmed death 1 (PD-1), programmed death receptor-1 ligand (PD-L1) and clinical pathological parameters, early postoperative recurrence and metastasis in patients with esophageal squamous cell carcinoma. \u0000 \u0000 \u0000Methods \u0000The retrospectively analyze of Paraffin tissue specimens and clinical pathology data in 58 Patients undergoing radical esophageal squamous cell carcinoma surgery from January 2015 to January 2017 in the 910 hospital of PLA Joint Service Support force were performed.Expression of PD-1 and PD-L1 in esophageal squamous cell carcinoma and normal esophageal mucosa were detected by SP immunohistochemical staining.The positive expression rates of PD-1 and PD-L1 in normal esophageal mucosa and esophageal squamous cell carcinoma were compared.the relationship between PD-1 and PD-L1 and gender, age, family history, depth of tumor invasion, degree of differentiation, lymph node metastasis, and TNM staging were analyzed.Follow-up was performed by outpatient consultation and telephone consultation.The recurrence and metastasis of early postoperative (≤1 year) was analyzed.The PD-1 and PD-L1 in esophageal squamous cell carcinoma were analyzed in patients with recurrent metastasis and non-relapsing and metastasis. \u0000 \u0000 \u0000Results \u0000The positive expression rate of PD-1 in esophageal squamous cell carcinoma was 37.93%(22/58), which was significantly higher than that in normal esophageal mucosa 15.52%(9/58). The difference was statistically significant (χ2=7.440, P=0.006). The positive expression rate of PD-L1 in esophageal squamous cell carcinoma was 43.10%(25/58), which was significantly higher than that of normal esophageal mucosa 18.97%(11/58). The difference was statistically significant (χ2=7.894, P=0.005). There was a difference in the positive expression rate of PD-L1 between different infiltration depth and TNM stage, P 0.05). The positive expression rate of PD-L1 in the recurrence group was 71.43% (10/14), and that in the non-recurrent group was 34.09% (15/44). The difference was statistically significant, (χ2=6.037, P<0.05). \u0000 \u0000 \u0000Conclusion \u0000The expression of PD-1 and PD-L1 in cancer tissues of patients with esophageal squamous cell carcinoma is highly expressed.PD-L1 is closely related to the occurrence and progression of esophageal squamous cell carcinoma, and it is also an important index affecting early recurrence and metastasis.Which can be selected as a new target for early diagnosis and treatment. \u0000 \u0000 \u0000Key words: \u0000Esophageal squamous cell carcinoma; Programmed death 1; Programmed death receptor-1 ligand; Clinicopathological features; Recurrence and metastasis; Correlation","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49290321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of body mass fluctuation on the prognosis of atrial fibrillation 体重波动对房颤预后的影响
Pub Date : 2019-09-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2019.05.013
Jie Li, Liping Zhang, P. Chao, Xiaoyang Chen, Yong Wang
ObjectiveTo investigate the effect of body mass fluctuation on the prognosis of patients with atrial fibrillation.MethodsThe patients diagnosed with atrial fibrillation in the People′s Hospital of Xinjiang Uygur Autonomous Region from 2012 to 2014 were selected.Among the 540 patients, the patients were divided into normal body(BMI ≤ 25 kg/m2), overweight (25 kg/m2
目的探讨体重波动对心房颤动患者预后的影响。方法选取新疆维吾尔自治区人民医院2012-2014年诊断为心房颤动的患者。在540名患者中,根据基线体重将患者分为正常体重(BMI≤25 kg/m2)、超重(25 kg/m2
{"title":"Effect of body mass fluctuation on the prognosis of atrial fibrillation","authors":"Jie Li, Liping Zhang, P. Chao, Xiaoyang Chen, Yong Wang","doi":"10.3760/CMA.J.ISSN.1008-6315.2019.05.013","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2019.05.013","url":null,"abstract":"ObjectiveTo investigate the effect of body mass fluctuation on the prognosis of patients with atrial fibrillation.MethodsThe patients diagnosed with atrial fibrillation in the People′s Hospital of Xinjiang Uygur Autonomous Region from 2012 to 2014 were selected.Among the 540 patients, the patients were divided into normal body(BMI ≤ 25 kg/m2), overweight (25 kg/m2<BMI<30 kg/m2) and obesity (BMI ≥ 30 kg/m2) according to the baseline body mass.The median body mass fluctuation of the three groups was 2.40 kg, and according to the median body mass fluctuations, the patients were divided into two groups: the high body mass fluctuation group and the low body mass fluctuation group.Changes of body mass were observed and the incidence of cardiac death, acute coronary syndrome, chronic heart failure, cerebral embolism and peripheral vascular embolization were monitored.ResultsDuring the follow-up period, as the increased of body mass fluctuation, the incidence rate of end point events also increasing continuously.The main end point event was used as the composite end point (HR(95%CI): 1.03 (1.06~1.15); P=0.02), including the cardiogenic death (HR(95%CI): 1.04 (1.09~1.12); P=0.03), the incidence of acute coronary syndrome (HR(95%CI): 1.04 (0.96~1.08); P=0.06) and the heart failure incidence (HR(95%CI): 95%CI: 1.04 (1.01~1.09), P=0.04). The secondary endpoint as composite endpoint (HR(95%CI): 1.16 (1.15~1.31); P=0.01), including the cerebral embolism (HR(95%CI): 1.21 (1.23~1.54); P=0.01) and the peripheral vascular embolism (HR(95%CI): 1.03 (0.91~1.03); P=0.01). After adjusting for all confounding factors, the quartile group with the highest body mass fluctuations was 6.2% higher in the main endpoint event than the lowest body quartile and 14.2% higher in the secondary endpoint.The occurrence of major endpoint events and secondary endpoint events in the quadruple group with high body mass fluctuation was significantly higher than that in the quadruple group with the lowest body mass fluctuation(main endpoint: 4.4% vs 10.6%; (HR(95%CI): 1.86 ( 1.53 ~ 2.41); P<0.01; secondary endpoints: 15.6% vs 29.8%; (HR(95%CI) 2.12 (1.56 ~ 3.58); P<0.01). The main endpoint events were cardiogenic death (HR(95%CI): 1.85 (1.73~2.3); P<0.01); incidence of acute coronary syndrome (HR(95%CI): 1.02 (0.94~1.35); P=0.08); incidence of heart failure (HR(95%CI): 1.48 (1.28~1.62); P<0.01); secondary endpoint events were cerebral embolism (HR(95%CI): 2.23 (1.93~3.91). (P<0.01), peripheral vascular embolism (HR(95%CI): 1.05 (0.96~1.42); P=0.13). For patients with normal body mass, body mass fluctuations had no significant effect on prognosis (main endpoints: 6.1% vs 5.3%; (HR(95%CI): 1.04 (0.94 ~ 1.43); P=0.064; secondary endpoint : 16.7% vs 17.4%; (HR(95%CI): 1.12 (0.84~ 1.09); P=0.072), but for overweight and obese patients, the greater the fluctuation of body mass, the higher the incidence of adverse events (main endpoint: super-recombination: 5.8% vs 11.2%; (HR(95%CI): 1.532 (1.135","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45452621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in mechanism and management of adverse drug reactions targeting anti-angiogenesis drugs 针对抗血管生成药物的药物不良反应机制及处理研究进展
Pub Date : 2019-09-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2019.05.022
Jianfang Shao, Bin Dong, Qinghua Zhang
Angiogenesis plays an important role in the occurrence, development and metastasis of malignant tumors, and anti-angiogenesis has become an important therapeutic method in molecular targeted therapy of tumors.At present, the commonly used anti-angiogenesis drugs include monoclonal antibodies (bevacizumab), tyrosine kinase inhibitors (sorafenib, sunitinib), and endothelial cell growth inhibitors.The adverse reactions of different kinds of targeted anti-angiogenesis drugs are different.To grasp the mechanism of adverse reactions and the treatment measures of related adverse reactions of these drugs will improve the tolerance of patients receiving this kind of drugs, and at the same time, the prognosis of patients will be further improved. Key words: Targeted therapy of tumor; Anti-angiogenie drugs; Adverse reactions
血管生成在恶性肿瘤的发生、发展和转移中起着重要作用,抗血管生成已成为肿瘤分子靶向治疗的重要治疗手段。目前常用的抗血管生成药物包括单克隆抗体(贝伐单抗)、酪氨酸激酶抑制剂(索拉非尼、舒尼替尼)和内皮细胞生长抑制剂。不同类型的靶向抗血管生成药物的不良反应不同。掌握这些药物不良反应的发生机制及相关不良反应的治疗措施,将提高患者对该类药物的耐受性,同时进一步改善患者的预后。关键词:肿瘤靶向治疗;Anti-angiogenie药物;不良反应
{"title":"Advances in mechanism and management of adverse drug reactions targeting anti-angiogenesis drugs","authors":"Jianfang Shao, Bin Dong, Qinghua Zhang","doi":"10.3760/CMA.J.ISSN.1008-6315.2019.05.022","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2019.05.022","url":null,"abstract":"Angiogenesis plays an important role in the occurrence, development and metastasis of malignant tumors, and anti-angiogenesis has become an important therapeutic method in molecular targeted therapy of tumors.At present, the commonly used anti-angiogenesis drugs include monoclonal antibodies (bevacizumab), tyrosine kinase inhibitors (sorafenib, sunitinib), and endothelial cell growth inhibitors.The adverse reactions of different kinds of targeted anti-angiogenesis drugs are different.To grasp the mechanism of adverse reactions and the treatment measures of related adverse reactions of these drugs will improve the tolerance of patients receiving this kind of drugs, and at the same time, the prognosis of patients will be further improved. \u0000 \u0000 \u0000Key words: \u0000Targeted therapy of tumor; Anti-angiogenie drugs; Adverse reactions","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47609870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中国综合临床
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1